Biohaven Competitors and Similar CompaniesClear all

Biohaven's competitors and similar companies include Genentech, EMS Pharma, Alembic Pharmaceuticals and UCB.

	Biohaven Biohaven (also known as SpinCo, formerly known as Biohaven Research) is a biopharmaceutical company that develops therapies for diseases such as migraine, depression, bipolar, and schizophrenia.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 2022	Founding Date 1976	Founding Date 1964	Founding Date 2010	Founding Date 1928
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations New Haven, US HQ Road Town, VG	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations BR HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 190	Employees 18,077	Employees 12,7441% increase	Employees 14,858	Employees 9,052
Valuation ($)	Valuation ($) 5.2 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)
Net income	Net income ($738.8m) (FY, 2025)	Net income N/A	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)